ElizabethOHexnerMD

PubMed

• 2 citations
  Cytokine-mediated CAR T therapy resistance in AML.
  Anand S Bhagwat, Leonel Torres, Olga Shestova, Maksim Shestov, Patrick W Mellors
  Nature Medicine. 2024-12-01
• Inconsistent Reporting and Definitions of Time-to-Event Endpoints in CAR T Clinical Trials: A Review.
  Connor B Grady, Yimei Li, Shannon L Maude, Elizabeth O Hexner, Noelle V Frey
  Transplantation and Cellular Therapy. 2024-11-26
• Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group.
  Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, Ingrid Vasova, Francis Ayuk
  Transplantation and Cellular Therapy. 2024-11-26

Journal Articles

• CD44: Expanding the toolKIT  
  Elizabeth Hexner, MD, Blood
• Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium Difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients  
  Edward A Stadtmauer, James K Mangan, Elizabeth O Hexner, David L Porter, Daria V Babushok, Jacqueline Smith, Craig W Freyer, Mindy Schuster, Noelle V Frey, Selina M Lu..., Clinical Infectious Diseases
• Germline Duplication of ATG2B and GSKIP Genes Is Not Required for the Familial Myeloid Malignancy Syndrome Associated with the Duplication of Chromosome 14q32  
  David B Lieberman, Daria V Babushok, Timothy S Olson, Stella T Chou, Elizabeth O Hexner, Nature

Abstracts/Posters

• Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
  Elizabeth O. Hexner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
  Elizabeth O. Hexner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to El...
  Elizabeth O. Hexner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Final Results of Prospective Treatment with Pegylated Interferon Alfa-2a for Patients with Polycythemia Vera and Essential Thrombocythemia in First and Second-Line Set...
  Elizabeth O. Hexner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Outcomes of Allogeneic Stem Cell Transplantation for AML and MDS Based on Pre-Transplant MRD Status By Next-Generation Sequencing 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018